Tylvalosin tartrate has resistance activity against many Gram-positive bacteria and some negative bacteria, including mycoplasma, vibrio, spirochete and large viruses. It has unique curative effects on Mycoplasma gallisepticum in chickens, porcine epidemic pneumonia, swine dysentery, etc., and is suitable for the prevention and treatment of atrophic rhinitis, avian cholera, chronic respiratory diseases in chickens, pneumonia caused by Mycoplasma bovis in calves and other diseases. This product has a wider safety margin than tylosin and is an ideal drug with obvious curative effect on mycoplasma diseases in livestock and poultry.

It can inhibit the replication of PRRS virus, stabilize PRRS in pig farms, and prevent and treat mycoplasma diseases, infectious pleuropneumonia, streptococcus, ileitis, spirochetosis, etc. in livestock and poultry.